#ACR21 Ab#1166. How many of your pts use marijuana? ⭐️Probably more than you think! ▶️57% have tried, >50% use at least weekly ▶️67% doctors thought <20% of pts use it 🔥Pts over 40 yo MORE likely to report marijuana use @Rheumnow https://t.co/0uW8rZvf1k https://t.co/ShMnR0faHr

• https://bit.ly/3CWLrVa

#ACR21 #Abstr1461 Post-hoc analyses from BLISS-LN #lupus showed independent of IV Steroid pulses during induction, at Wk104: 💠More pts in Belimumab achieved PERR and CR vs PBO 💠More pts in PBO had flares and kidney event/death vs BEL @RheumNow https://t.co/pLxAI2RDRJ https://t.co/8CZMq3RTls

• Belimumab Improves Renal Responses in Patients with or Without Steroid Pulses D…

Lianne Gensler presenting "Exercise Strategies for Ankylosing Spondylitis". Not all physical activity is similarly beneficial. Learn more now by attending her session at #ACR21! @CherylKoehn @ArthritisNetwrk @EIM_Canada @exerciseworks @PhysioKTBroker @jwhittak_physio @JasminKMa https://t.co/rER3EdCohO

@rheum_cat I want to run into an ASAS meeting and shout "seronegative spondyoarthropathy"! https://t.co/WkEz5BMttJ

@LianneGensler Is exercise anti-inflammatory? In this study, healthy volunteers were infused with E coli endotoxin 😲 and their TNF levels measured. TNF levels were compared between groups at rest and groups exercising. TNF levels were ⬇ by exercise. #ACR21 https://t.co/Ylw7SQX32y

@rheum_cat @alhkim You're beating @RheumNow, quite impressive @rheum_cat !

MRI Imaging in RA and SpA: Dr. Sheila Reyes ( @RHEUMarampa) Dr. Sheila Reyes discusses abstracts #0468 and #0469, presented at the #ACR21 annual meeting. https://t.co/MeVia60BNa https://t.co/WRgCifpioQ

• https://bit.ly/3o8Uexe

#ACR21 #SLE #COVID19 Use of Telemedicine for follow-up of SLE in COVID19 Wait times lower for telemedicine Patient satisfaction higher in telemedicine group More hospitalization, higher switch to in person follow up in telemedicine https://t.co/Y21Vki1uDP

#ACR21 #SLE SLE – Treatment: New Agents, Old Agents Pooled data from 2 phase 3 trials (TULIP 1 and 2) ⏬LLDAS is an attainable T2T endpoint in adult SLE trials ⏬Anifrolumab treatment associated with earlier and more sustained LLDAS in adult SLE https://t.co/bxGlVsJOZC

1) Trial enrollees were likely partial/non responders to MMF at baseline (NIN had clean slate) 2) Unblinding from diarrhea from NIN, likely tilts toward NIN d/t PLBO effect 3) MMF-PLBO may have had dx longer than NIN-PLBO, missed critical early window to affect progression?

Interesting thoughts from Dr. Distler re:nintedanib & MMF in SSc-ILD Agree we should look into MMF-nintedanib combo, but this graph makes me think MMF > NIN Why would that be? Unlike NIN, MMF pts were NOT randomized, which likely favors NIN for a few (speculative) reasons: https://t.co/ZHBD8x74PM

ACR Convergence 2021 attendees – join us this evening, Monday, Nov. 8, from 6:00 to 6:30 PM ET, for the virtual #ACR21 Tweet Up! Add to your agenda → https://t.co/lisFBp1scO #RheumTwitter https://t.co/3pO3quH2Sm

• https://acr.tw/3ka7CQA

Hard to keep up with all the good news. Congrats to @philseo, Program Director extraordinaire and Director of the Johns Hopkins Vasculitis Clinic, for receiving the ACR Distinguished Clinician Scholar Award. #ACR21 @HopkinsMedicine @HopkinsMedNews https://t.co/FQb2W6KpYT

8M415 Gout Imaging Advances: Ralf Thiele on US🔊and DECT US>DECT: DECT needs a minimal density of MSU; DCS, tophi <2mm, liquid tophi may not be detected; US can show hyperemia DECT>US: DECT can show areas that may be overlooked from standard protocols 💡Bonus:stay around for Q&A https://t.co/G7yQaj9fHw

🔥Continued, More Clinically Meaningful data in #SSc #ILD from #Nintedanib in >52 wk SENSCIS & SENSCIS-ON(open-label ext)#ACR21 Dr Distler ✨MMF likely to stay 1st line, then Nintedanib ❓Is it time for MMF + Antifibrotic upfront?? Await SLS-III;Data so far seems supportive https://t.co/JWXMlsJgmc